Begin main content

Reports

We found 6096 result(s)

2019 CADTH Symposium

Event Date: April 14, 2019 - April 16, 2019
Result type: Events

CADTH will be hosting its annual Symposium at the Shaw Centre in Edmonton, Alberta, from April 14 to 16, 2019. For more information, please visit the CADTH Symposium website. Questions may be sent by email to symposium@cadth.ca.

dolutegravir / lamivudine (TBC)

Last Updated: January 23, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: dolutegravir / lamivudine
Indications: HIV-1 infection

  • Brand Name: TBC
  • Manufacturer: ViiV Healthcare ULC
  • Project Number: SR0601-000
  • Project Status: Pending
  • Submission Type: New

Tags

Infectious Diseases, Pediatrics, HIV/AIDS, Infectious diseases, Pediatrics

ALK Inhibitors for Non–Small Cell Lung Cancer

Published on: January 23, 2019
Result type: Reports
Product Line: Technology Review

Lung cancer is the second-most commonly diagnosed cancer in both men and women, and is the leading cause of cancer deaths in Canada. Rearrangement of the Anaplastic Lymphoma Kinase (ALK) gene drives the development of about 5% of non–small cell lung cancers (NSCLC). Inhibitors of ALK can effectively delay progression of these malignancies and ar...

  • Project Number: HE0017

Call for Patient Input and Clinical Experts: dolutegravir/lamivudine

Published on: January 23, 2019
Result type: News

CADTH has received the following notice(s) of pending drug submission(s).  Brand name TBC Generic name dolutegravir / lamivudine Manufacturer ViiV Healthcare ULC Indication(s) HIV-1 infection Project Number SR0601-000 Call for patient input 2019-01-23 Patient input deadline 2019-03-14 Submit patient input Submit Register as Clinical Expert Regis...

Additional Precautions for Methicillin-Resistant Staphylococcus Aureus, Vancomycin-Resistant Enterococci and/or Extended Spectrum Beta-Lactamase-Producing Organisms: Clinical Effectiveness and Guidelines

Published on: January 22, 2019
Result type: Reports
Product Line: Rapid Response
Research Type: Devices and Systems

  • Project Number: RA1004-000

Tags

Infection Control, beta-Lactam Resistance, Methicillin-Resistant Staphylococcus aureus, Patient Isolation, Patient Isolators, Quarantine, Vancomycin Resistance, Infection control, Precaution, superisolation, quarantine

CADTH pan-Canadian Oncology Drug Review

Published on: January 22, 2019
Result type: General Content

The pan-Canadian Oncology Drug Review (pCODR) is an evidence-based, cancer drug review process. The pCODR process is designed to bring consistency and clarity to the assessment of cancer drugs by reviewing clinical evidence, cost-effectiveness, and patient perspectives, and using this information to make recommendations to Canada's provinces an...

Tags

pcodr, Pan-Canadian Oncology Drug Review

Call for Feedback: Optimal Use of Minimally Invasive Glaucoma Surgery: Recommendation

Published on: January 22, 2019
Result type: News

A document related to the project entitled Optimal Use of Minimally Invasive Glaucoma Surgery: Recommendation is now available for feedback from all interested stakeholders. Project Call for Feedback Feedback Due By Optimal Use of Minimally Invasive Glaucoma Surgery: Recommendation 2019-01-22 2019-02-05 Consultation Document Product Type Submit ...